Skip to content
Screener

Catalyst Biosciences CBIO Q4 2025 Annual earnings

Reported February 26, 2026 · After market close

Revenue$10.8MBeat by $844.0K
EPS-$4.01Miss by $1.79
Revenue estimate$10.0M
EPS estimate-$2.22

Next report

Date not yet announced

FAQ

When did Catalyst Biosciences report Q4 2025 earnings?
Catalyst Biosciences (CBIO) reported Q4 2025 earnings on February 26, 2026 after market close.
What were Catalyst Biosciences's Q4 2025 revenue and EPS?
Catalyst Biosciences reported revenue of $10.8M and eps of $-4.01 for Q4 2025.
Did Catalyst Biosciences beat estimates in Q4 2025?
Revenue beat the consensus estimate of $10.0M by $844.0K. EPS missed the consensus estimate of $-2.22 by $1.79.
How did Catalyst Biosciences's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 19949.6% from $54.1K a year earlier and eps declined 3545.5% from $-0.11.
Where can I find Catalyst Biosciences's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001628280-26-011988) and the 10-K periodic report (0001628280-26-011983) directly on SEC EDGAR. The filing index links above go to sec.gov.